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Summary 
The presence of N sequences  in the complementarity  determining region 3 (CDR3) of the rearranged 
immunoglobulin H  chain is developmentally regulated: N regions are generally present in the 
DJH joinings of adult B cells but are often absent in fetal B cells. Analysis of the CDK3 in 61 
B precursor acute lymphoblastic leukemias indicated that 87.5% of the leukemias obtained from 
children ~3 yr old lacked N  regions at the DJH junction. In contrast, in children >3 yr old, 
only 11.1% of the leukemias lacked N regions at this junction, a frequency similar to what we 
have observed in B cells from children and adults.  These findings suggest that the majority of 
leukemias presenting within the first 3 yr of age arise from an in utero transforming event. 
H 
'Ypervariability  within the CDR3 of the human Ig H 
. chain is initially generated at the time of VDJ joining 
by the recombination of multiple V., D, and J. gene seg- 
ments (1-3).  This VDJ recombination process is dependent 
upon two recombinase enzymes, RAG1 and RAG2,  since 
mice deficient in either gene fail to produce lymphocytes with 
rearrangements in their Ig or TCK loci (4-8). Exonucleo- 
lytic activity produces joinings in which germline nudeo- 
tides are lost from the ends of the joined segments (1-4). 
Variability is increased when nontemplate-derived  nucleotides 
(N regions) are added between  joined gene segments through 
the action of another enzyme, terminal deoxynucleotidyl trans- 
ferase (Tdt) 1 (1-4).  In both IgH and TCK rearrangements, 
palindromic (P) mono- or dinucleotides may be found adja- 
cent to a recombined gene gene segment when the segment 
is present in its entirety. These germline-encoded  nucleotides 
arise from a flip-over mechanism of the 5' end of one strand 
of the joining segment (9). 
The developmental regulation of N  region addition has 
been demonstrated in both mice and humans (10-13).  DJ. 
joinings that lack N  regions are found more frequently at 
the fetal stage of development. No more than 5% of the DJ. 
junction sequences of B lymphocytes present in murine fetal 
liver contained an N region, whereas in newborn mouse spleen 
and  liver,  5-23%  of  the  DJ.  junctions  had  N  regions 
1 Abbreviation used in this paper: Tdt, terminal deoxynucleotidyl transferase. 
(10-12). In contrast, a significantly higher percentage of DJ. 
junctions with N  regions (64-73%) were found in B cells 
from adult (4-8 wk) murine spleen (10-12). A similar trend 
was found in human B cells; evaluation of >500 DJ.joining 
DNA sequences obtained from human fetal, neonatal, and 
adult lymphoid tissue revealed N  regions at the DJ. junc- 
tion at frequencies of 68 %, 86 %, and 91-100%, respectively 
(13, 14). Together, these observations suggest that CDK3 
sequences lacking N  regions at the DJ. junction are repre- 
sentative of a DJ. recombination event that occurred during 
the time of fetal development when TdT activity may have 
been absent.  Indeed, in the murine system, TdT levels rise 
slowly in the developing thymus, which correlates with the 
absence of N regions in fetal TCR-y/6 rearrangements (15, 
16). Similarly, in the murine B lymphoid system, TdT was 
not detected in fetal liver but was demonstrated in adult bone 
marrow B lineage cells (16). 
The functional significance of the absence of N  regions 
in the early stage of development is not dear. Gu et al. (12) 
speculate that the absence of N regions implies predominant 
expression of germline-encoded specificities. Thus, idiotypic 
interactions in a germline-encoded network might play a func- 
tional role in the development of the antibody repertoire early 
in ontogeny. In newborns, Feeney (10) found a higher per- 
centage of N regions in productive vs. nonproductive rear- 
rangements  and  speculated  that  this  increase  suggests  a 
preferential  activation of B cells whose IgH sequences con- 
tain N regions by antigens or cellular interactions. Alterna- 
tively, IgH sequences with N regions might have an advan- 
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enhanced binding to surrogate  L chains. 
B lineage acute tymphoblastic leukemia (ALL)  of child- 
hood results from the transformation orb precursor cells and 
their clonal expansion (17-19).  We reasoned that if lack of 
N regions at the DJ. junction was a marker for fetal-derived 
B cells, then leukemias arising from an in utero transforming 
event  should  show  a bias  for  DJ. joinings  that  lack  N 
regions. Furthermore, the age distribution ofleukemias lacking 
N  regions  at their DJ. joinings might provide insight into 
the length of time required to develop clinical disease from 
the time of the transforming event. 
Materials  and Methods 
Source of Celk  Bone  marrow sampies with >70% lymphobhst 
replacement were obtained at  diagnosis from 63 patients (6  mo 
PnTIEH1  nGE  D 
CG6-11t  ~,S  (LAG)  RGTGCCRGOTGCTnT 
C1-102  5  (ill)  66TnTnnCIGGn 
CI-IIG  (At)  OnGTnTMGNGC? 
C2GG-II6  ?  (At)  TGTn$CDGOTCGCCr  TCC 
C2DG-t29  (21/IG)  TDTBGTIGCGTITGGBBASlTRTCOIT~TROG  (C) 
C20n-t36  (knG)  ?nTICBTRCGIRC|TOCORGCfGC  R 
C?6-10S  14  (HG)  GnOTOTRGCG10TCGC 
C?6-1~l  (XPt)  OTnTTRCGRTITTTOGRGTORTT~TTn 
C130-111  10  (XPI)  RGTGGTTfilCCC? 
0135-124  IO,5  (LnZ)  OT60ilMIOTGGT 
055-117  22  (LOt)  GlfFGTRr 
C85-113  24  (XPI)  GnTRTTTTGnCTGGITRTTflT 
GOD-lOG  ~$.5  (Lnl)  RCTRGTGOTGTDTGOT~TnC  OfF 
cgo-IIO  (KPI)  nTTITIROTGGITn 
C413-8G  25  (XP'I)  C6616RI G (HI)  GGGT~ 
C433-1G1  (NP1)  OnBAGTT 
ClOG-f)1  2T~  (~1)  TATAGCAGCDGCTGG 
C17n-104  ZT.S  (Xn*l)  TCOTAT~TTCGGOBRGT 
C1TO-105  (~nl)  TRCGflTRTTTTGGOTGBTTDT 
C?~l-g4  )0  (KI)  60TTnC 
C?TD-IOI  325  (rig)  TOOTDGTTGTG  (OIRI)  00TDCCC 
C??O-10T  (NO)  T~RCTGGGOA  TOng (DI01)  TTAOGABOTITOR 
CM~-~DS  ~).S  (HO)  0Tn~CttGGG 
ci|g-l$  ~],5  (XP'I)  nlltllGflllGIAI 
C50-101  ]6.$  (L01)  nGGRTDTTGTRCC~  00CGGO 
C61-105  (XPO)  ~TTTTT|GflGTGITTRTCTRTRTG00  CGC 
050-122  (El)  8TOGDTDIGGTUTCICOD  (HA)  nGCflOCROCTGGTnC 
C25-1GS  )o  (~1)  610COGGCT~l  ?GEl|GO 
CZGD-gB  ~G  (N~)  GGGTATAGC~IACTGGTC  TOTC 
C206-11G  115  (inl)  OTTTTOOCT66110  AACCCCCT600 
C38|-IG?  135  (XO)  TRRCTAIGGfl  KGDT  (LI)  GTOTGTO  n 
C52T-I12  44  (L4)  TnGTDGTDCCDGOTGCTOTO  O 
C$2?-121  (Lt)  56TGIRT|CIRTRC  TGGO 
C6g-104  q4.S  (At)  TROAGTM~CTar  555(1) 
COg-TOG  (xn'l)  ATTRCSATITTTDGGGTSGTTG 
CIg?-t3g  45  (Lnl)  TnTT|TAGTDw  TOT (XP$)  ccnTflROCGR~RTDO  nTCCT 
C~32ol37  16  (LR2)  GGRTATInTRGTGGIGGTRGCTGC  OTGO (K4)  nOGGCTCnRTGG4  fiTGG 
CT2-gOR  qo  (L~4)  GTAGTRGTnCCGGCTDCT  TnGGBGOT# 
C34r  47  (NO)  RCCTOOGGR  TCCGGTTOO 
~17t-tl3  ~7.5  (~Ptn)  TRIT~CT~TGGTTCGOGORGT  CnC 
~$~g-~OO  S~  (~)  TnTAiiI~RGD  B~CTOOT 
Clg9-I~I  50  (LnO)  GRTflTTOTRGTHGTflCCflGCTGCTnTflC 
cg2-~3  63  (~Pt)  nCBHTnTTTGRCTGGITRTTR  OGCCCOTOGG 
C515-116  64.S  (XP4)  GTflTTnCGHTTTTTODRBI|GTTflT  CORnTG 
C113-105  665  (nl)  nGC160  GTCnTO 
C113-146  (LRO)  RCCnOCTOCTnTSGC  OG (L~D)  flORnTRT161nGTGGTDGTROCTOOTnCTO 
C91-~24  ~8,5  (2I/G)  GTDT?ACT~TORT~GTRGTGG~T~T1~CTG  (DIAl)  GGGGCOCTIGGR  n 
C~36-114  ?0,5  (LRI)  GATRTTGTROTflGTnOCRGC?GCT 
cSS~-~G4  ?0,5  (nil  RCmlTROqCT  ROnORRnTGn~GTn  (21/g)  ~TGRTR  nn 
C422-tl1  ?1  (L03)  TnTT|TGGTGGTG~CTGCTnT  5RCCT (HQ)  nCTGOnGGR  TIC10 
C432-90  7)  S  (DrnZ)  5GnOGr  O~nOGCT1 
CO)Z-gO  ([4)  GGRTRCnOCTnTOGT 
~221-123  ?4  (2]/9)  GTRTTRCTRTGRT~GTRG16GTTAC  CnGnOO 
CIqO-)O6  GO  (ill)  flRCTGDnnC  CCTTfl 
CI3G-II4  OS,$  (fl~)  OGOTRTnOC~GTOGCTGG  GGTO 
C10Z-10g  07,5  (H1)  OTRGC~GCDOCTOG 
nLLt-155  IG2.5  (~1110)  TTTBOGG~GTTnT  GGCCG5OTTCT  (Din2)  00RCCOOGTTGCCTOn  GTGG5 (~PI)  TnCO~CTTTGnGT  R 
flLLI-160  (21/G)  nTTROT~TGnTRGTnGIGGTTRT  CGGGCOOTGOGCRCCGGGGRTRBGGOT  (21/9)  RCTRTGRTROTRGTGGTTR1  C (Gin)  GGGCGTGOGT 
C52-~2|  ~Z  (LAD)  GG~T~1~|TRGTRGTAO~GCTGGTRT 
~52-132  (Ln})  RGCRInTTGTGOIGGTGROTGCTnCT  GnGCRRC(GT) 
~60-60  ~20~$  (oln2)  CCOOCnGCOCCG  GGACT 
C24-)04  I~O  (XP'I)  OGTTOGGGG  CGCCGGRT 
C137-121  1t2.5  (Nt)  TGGORGTGGOTGDlnC  RR  (GIRl)  GGGCGGGCCRTCCGTRRGG 
C230-1]3  ~46,5  (LBt}  TnTTOTROTRRTGGTGTRTGCT  C51TAT 
~ZDO-lZn  ~OO,S  (LAG)  TTGTGGG~GGGRCCAGCTGC  CO~CC~ 
C290-112n  156  (Lfl])  CnTflTTOTGOTGGTGRTTOCTRTT  RTn 
C211-12~  15g  (21/g)  OTnTTRCTnTGR106TRGTOGTTRC  CnGnGG 
C211-135  (XPO)  ORTlllTOORG16OTTfllT TCGTn (21/g)  nGTGGTTRRTT  C 
CID$-156  17~  (LR2)  ARGATRITGTnGTGGTOGTnGCTO~CTCT  (21/9)  GTRTTRCTATGnTnGTRGTGGTTnTTROTR  GGGCG 
C155-1)?  1?5  ((I)  GGCTnCGRTTR  BGTC (ZI/Y)  nTTRCTnTGR?nOIRGTGGTTRT?nGn 
C777-1)~  ~?8  (LRG)  nTTGIAOIAGIRCCflGOIGCTRT  TT  (LG)  TRGTCOnnGCGRO~TGCTRT  TGTnOC 
CT?I-ISD  (LnO)  GnTRTTOTnGTRGTRCORGCTGOTRT  CGnOGTCIT~TGG~CCCCR  (21/G)  nTTnCln1GACROTnGIGG?TRTT  TnnTCCCn 
C372-11S  10],5  (~PO)  GTGOTIn1TnTR  TT  (O~AI)  6nGO~TnO  OG 
CI38-105  19?  (LR1)  nGTROOROC  CCGG 
C2?2-11G  Igl  (KI)  RTGGTOGCTRCG  (Gin2)  GGGGGGTCCORGG  TnGG 
C252-11)  tgl.$  (LnG)  GnTnTIBTRGTnGTRCCnGOTOCTnT  ~GC 
CZ$~-12)  (~1)  GGGTDTGG  GTTT~?GGGT  (21/9)  TnTGnT~GTGGT  CC~TCCCCGn 
C/30-122  20q  (Ln2)  OOTGGTROOTCC  GAG 
~26G-105  2~05  (XP'I)  GGTTCGGGGAGTTn  GCTC 
~$07-g$  212.$  (~1)  nGTOOCT  GGCGOCGGG 
H  J  nEF 
CTnCTRCTnCTICTRCnTGGRCOTTGGBGGPAU~iAr  (6)  26 
RCTTTGRCTRCTGGGGCCR~A#OCT  (4)  27 
CTRCTACTRCGGRGCGTCTOBMr  (6)  2? 
nCT~CTnCTACTACGOTRGTCTEGGGCCRNOGRCGnr  (6)  27 
Tn~TRCTflCIRCT#COIOORCGTs  (5)  2? 
TRCTRCTRGDGTDGTCTAGG~r  (G)  27 
nACTOGTTCOnCCCCTGGOGCCKCCROCCCT  (S) 
Lo￿9162  (6) 
RTTnCTnCTROTRCTRCGGTnTGGRCGTCTGG|Or  (6) 
CTRCTRCTRCTDCGOTRTGGRCGTCT|GOICCF~IilRCC~C  (6)  20 
oTTNCTRCTflCTRCTACGGTRTGGflCBTGTOGHr162162  (6)  2? 
RCTOGTAAilCGRONBACCGT (t) 
6RCTRCfGOUCGR~Pmr  (4) 
LtCCTRCTRCTnCTnCGGTAIGGRCGTCTGGGKCF~4~Okqs  (6) 
TTGACTDCTGSGGC~ItlIWk~CCT (q)  27 
nTTRCIACTACNRCGGTDIRGTCTD|HCGG~qr162162  (6)  21 
tuGTRCTRCTRcIncGGIRTOODCGTC10GGGCCMmGGRCC~  (6)  2? 
tOLLeCw  (0)  27 
tOOTTCGRCCCDTGGG~Cr  ($)  2T 
TRCTTTGOCTDOTGGGGCCGGTSSMCCCT  (q) 
GOCTRCTG|GGCCDGGUCCCT (4) 
OTRCTOOGGCCAGOGDOCCCT  (4) 
aTOCITTTGRTRTCTSGGKGAHImCmDT  (3)  2G 
GRCTRCTAGGKCNglHIRfICCCT (I)  2? 
6RCTDCTGG~CRG~CCT  (4) 
GDCTACTGGI~CCIHIIGD~CCCT (4) 
TGGCTfGTGGGGCC~SNR~CCT (q) 
GGIGTGGGCGTCTGGGGs  (6)  27 
TTDISTDCOGBIICCHOGRRr162  (4) 
T~C?flCG$1RTGGDCGTCTGGGGCcILqOliI~qccRC  (4) 
TOTIGGICCHOH~CR~T ()) 
TGOTTCGflCCCCTGEGGCCG$EGDRCCCT  ($) 
TnC?TTGnCTRCTOGGGOORGGGnnCCCT  (4) 
nOTROTITOROTRCTGAGGCr163163  (4) 
tTGRCTGC106G$r  (4) 
TnCTRCTACGGTRTOGACGTCTOGGGr  (GJ  2? 
nOTnCTnC?nCOOTnTSGRCGTCTIGIgCCMIOGRr  (6)  21 
CI|(HIICCRGIAGAs  ($) 
GHCTROTGGGGCOGGGGRRKCCT  (4) 
ARCTGOTTCGnCCCC10nG60r  (5) 
nCT~ISGGGGDAHGMKOCT (4) 
flCTACrRC?ACGGTRTGGAC|TCTSGAACCG~GCAC  (GJ 
CTRCTACGGTRTGGRCOTOTnGOGCDRRIGGRCCRC  (6)  2n 
RTDCTTTTGRTRTCTGDGGCC~II~CART  ()) 
nTOOTTTTGnTRTCTGGHr  O) 
cTAC~nCT~CTRCGGTOTGGRCGTCTGGGGCCRDGGGGC~GC  (6) 
TG~CTRs163  (4)  25 
oRCTGGTTCGACCCTGGGGCCDGODGACC~T  (5)  2G 
TIGI~C~4~RDCCCT  (t) 
TGGINK%~IITGDCRCCCT (I) 
TTTORCT#CTOOOOCCROSGflACCCT  (4)  26 
R~TnCTTTGHCTRCTBGGGCCRGGGRRCCCI  (1)  26 
nCTTTGRCT~CTGGGGCCflAHP~CCCT  (q)  26 
50nCTflCTACGGTRTGORCw  (G) 
ATOCTTTTGnTnTO?OOGGOCGRGGGflCMT  (3)  2? 
TTGRCTDCTGGGGCCDGGGMCCCT  (4)  26 
TGGGDCC~GG~CCCT (4)  24 
CTGOKCRGGGGCOCT (1)  24 
CT~CT~C1nC~TOOnCSTGTGGGGCCDDGIG~CGRC  (6)  2B 
nCTRCITTGR~TRCTGGGGCCROOGARCCCT  (I)  2G 
TnCTGGGGCOROG~RCCCT (4)  21 
TnTBGACOTCTGGGGCCRRIOGRCCRC  (6) 
TRCTTTGRCTACTOGBGCGROGGRRCCCT  (t)  28 
TnOTnCTRCT~CCGGTGCGTCTGGGGCCRDO6GRCCRs  (6) 
TT~CTRCT~CTnCTRCTRCRTGGflCGTCTGOGGC~A~GGGAr  (6) 
OG~CC~C (6)  2? 
ACTTTOnCTA040GGGOO~GGGRD0r  (I)  26 
TT~CT~CTRCTnCTRC~TGGnCGTCTOOODCCDRGGGACCRC  (5)  26 
CTRCTRCTnCTnCGGTRTGGflCGTC?GOGGCCRR~GRCCnC  (5)  2? 
cLacTRCIRC?nCGGTnTOGRCGTC155GGCCRR60ORCCRC  (6) 
CT~OTGOGGCCRGGGR~CCCT (4) 
TITGRCTA~TGGGGCCABOOflAC~T  (1) 
CTRCTRCGGTRTGGRCOTCTGGGGCOnflSGGDCCnC  (6) 
CTGOTTCGRCCCOTGDOOCOnOGGDRGCCT  (S)  20 
CTGOTTCG~CCCCTGGOOOCRGGGAflC~CT  (5) 
OnCTPCTGOGGOC#OGGflnOCCT  (q) 
nOTRCTGGOGCCOGOGMCCCT (q) 
RornCTnCTRCTROGGflG~TCTGGGGCCflRGw  (6)  2? 
fl?nACTOG?TOOflCCCCTOGOGCC~GGGR~CCCT  (5)  26 
GOTflTGGRCGTCTGGGGCCROGOGRCCflC  (5) 
Figure 1.  DNA sequence of the DJ. region from 61 cases of B lineage lymphoblastic leukemias. The first column indicates the sequence code (case 
number and the length of the CDIL3.  including the V, and J. primers). Each sequence is subdivided into D  (and when applicable multiple D  with 
intervening N  regions),  N, and J. (5' end) regions. Germline D  and J. segments  with maximum homology to the segments used in the CDR3 se- 
quences are shown to the left and right of these segments,  respectively. P nucleotides are enclosed by parentheses. 5' ends of J. segments  sharing ho- 
mology with the 3' end of the D segment are indicated  by lower-case letters. References are shown where the indicated  sequences  have  been previously  published. 
1578  Fetal Type DJ. Joining in Young Children with B Precursor Leukemia to 17 yr) with ALL. Morphologically  normal bone marrow samples 
from three children (21-26 mo) with solid tumors obtained on rou- 
tine staging were used as a source of normal marrow B cells. Con- 
sent was given by the patients or their parents and by the Com- 
mittee for Protection of Human Subjects at the Children's Hospital 
of Philadelphia. 
Diagnosis of ALL in each patient was based on standard mor- 
phologic and histochemical parameters of the leukemic cells. The 
B cell precursor lineage of these leukemias was confirmed by im- 
munophenotyping in which all the leukemias  expressed the B lineage 
antigens CD19 or CD10 and were negative  for T cell antigens (20). 
DNA Amplification, Clonin,~ and Sequencing of CDR3.  Marrow 
cells were fractionated on a Ficoll-Hypaque gradient (d =  1.077) 
and genomic DNA was isolated from mononuclear cells by estab- 
lished procedures (21) or by rapid cell lysis using nonionic deter- 
gents (22). 
PCR was carried out as described (23) using an annealing step 
at 55~  for 1 min, an elongation step at 72~  for 30 s, and a denatu- 
ration step at 92~  for 1 min (14, 24). The V. and J. nucleotide 
consensus primers used in the PCR and the J, consensus (J.C) 
probes used for screening have  been described (14, 24). These con- 
sensus primers do not preferentially  amplify  CDR3 sequences con- 
taining specific  J. segments (14). Restriction endonuclease diges- 
tion of the PCR-amplified DNA, electrophoresis  in a 4% Nusieve 
agarose gel (FMC Bioproducts, Rockland, ME), purification, and 
cloning of CDR3-containing  bands were performed as described 
(14, 24). Positive  clones were picked up randomly (10-20Aample), 
and a double-stranded DNA template was prepared and screened 
by T lane sequencing. In each leukemia, from one to three different 
T lane sequences  were identified  that were present in multiple copies 
and were fully sequenced using the dideoxy method (25). In each 
normal marrow all the T lanes contained different sequences and 
m20 sequences were obtained from each marrow. 
DNA Sequence Analysis.  DNA sequencing data were analyzed 
for utilization of D and J segments using the sequence analysis 
software pack (Release 5; Genetic Computer Corp., Madison, WI) 
at the University of  Wisconsin and a Micro Vax II computer (Dig- 
ital Equipment Corp.,  Marlboro, MA),  according to described 
criteria (14). 
Results and Discussion 
80 DNA sequences of  VDJjoinings from 61 B lineage ALLs 
were analyzed for the presence of N regions at the DJ. junc- 
tion (Fig.  1). Overall, 31/80 (38.8%) DJ. junctions lacked 
N regions, a frequency higher than that reported for human 
adult tissues and similar to that found in human fetal tissue 
(13). When the percentage of leukemias lacking N  regions 
was analyzed as a function of age at diagnosis, a striking pat- 
tern emerged: in patients <3 yr old, 87.5%  (14/16)  of the 
leukemias were comprised entirely of CDR3 sequences lacking 
N regions; whereas in children >3 yr old, only 11.1% (5/45) 
of the leukemias met this criterion. 
The percentage of leukemias without N  regions in chil- 
dren <3 yr old was much higher than expected even when 
compared with data reported for normal human fetal liver 
or neonatal cord blood (13), whereas the frequency observed 
in children >3 yr old was close to that observed in adults 
(13, 14). To exclude the possibility that the paucity of N regions 
in these young patients could be due to an inherent abnor- 
mality in TdT  activity, we examined the DJ. joinings in 
lymphocytes obtained from the end of therapy marrows of 
three of these patients when residual leukemia was not de- 
tectable using PCR analysis (Fig. 2). N regions were present 
PATIENT  O 
CDR3 CODE 
N  J 
CIOO-91  (LA3)  6GRGGTGRT  C 
CIO0-91R  (LA2)  66TRGC  GR  (HQ)  TGGGGR 
C100-94  (K4)  GCTRT66 
CIO0-1O2  (21110)  6666RGCT (DFI6)  R~TACGGGGT  (T) 
ClOO-lO3A  (XQ)  CTRACTGG6GR  flGATTT 
CI00-106  (2119)  TRGTGGTTATRCCRC  (GIRl)  CCACCRC 
ClOG-lOG  (LR4)  GTRCCRGCTGCTRTRT  CGATCRCGGGG 
CIO0-109R  (HI)  GTATAGCAGTGGCTGGTAC  (A1)  CAGCCGGT 
CIOO-109A  (K1)  RGTGGCTRCGR  CGGGCC 
C100-115  (HI)  GGRTRGCRGTGGCTGGT  (DIAl)  C~CRCCC  C 
ClOO-115O  (AP4)  GRGTGG  GAGe (AP4)  TRCTRCGRTGTT  RTCTC 
C100-132  (AP'I)  AGGGTTC6  (LR3)  TGTTGATT6  6GT  ([I)  TGGATATRGTGGCTACGRT  CC 
C100-136  (M2)  TRCGGGTTA  GGACTT (LRS)  TACTRCTCT  TCGGGACCC (OlR2)  GGGCGGGG 
TTGACRACTGGGGCCAGGGRACCCT  (4) 
CTGGGGCCAGGGARCCCT (5) 
tLTGACTACTGGGGCCflGGGACCCT (4) 
ACTRCTTTGACTACTG666CCRGGGAATCCT  (4~ 
TTTGRCTRCTGGGGCCAGGGARCCCT  (4) 
TGACTRCTGGGGCCRGGGACCCT  (4) 
GGTATGGRCGTCTGGGGCCARGGGRCCRC  (6) 
CTTTGRCTACTGGGGCCRGGGflRCCCT  {4) 
AATTGGTTCGACCCCTGGGGCCAGGGRACCCT  (5) 
CTflCGGTATGGRCGTCTGGGGCCARGGGRCCAC  (6) 
RTTACTTTGRCRACTGGGGCCAGGGAACCCT  (4) 
RCRACTGGTTCGRCCCCTGGGGCCAGGGARCCCT  (5) 
CTACTATTATTACGGTATGGACGTCTGGGGCCAAGGGACCAC  (6) 
C17A-97  (2119)  RTTRCTATGRTA 
C17G-103  (LR4)  6TTGGTRGTR  (DIR1)  GGGGACGGGGT 
Cl?l-117  (XP'I)  6TTCGGGGRGTT  CAC 
CITe-121  (LR4)  TCTRGGAGTRCCRGCTGCTRTG  AGA 
CI7G-122  (HI)  AGCRGCRGCT6  CCR 
Cl70-122A  (8P'I)  6TRTTRCTATGGTTC66GGRGTTATT  TCC 
C178-135  (21/9)  TRCTRTGRTRGTRGTGRTTRTTRCTRr  (21110)  ATCRTTRC  C 
CI70-136  (GiRl)  66TCCTCCR66  CRC6 (2116)  RTT•TATGRTAGTAGTGGT  TCGTC 
C17A-136A  (LR4)  TRGTRCGGCRGCTGCTR  CA  (M2)  ARCCGGGR  C 
TRCGGTATGGACGTCTGGGGCCRAGGGRCCRC  (6) 
TRCGGTATGGRCGTCTGGGGCCRAGGGACCAC  (6) 
RRTRCTRCTRCTRCTRCGGTATGGRCGTCTGGGGCCARGGGRCCAC  (6) 
RCTACTACTACTACGGTATGGRCGCTCGGGGCCAAGGGACCAC  (6) 
ACTACTAC~RCTACGGTATGGRCGTCTGGGGCCARGGGACCAC  (6) 
CTACTACTACTRCGGTATGGACGTCTGGGGCCARGGGflCCRC  {6) 
AATACTACTACTACTACGGTATGGGGCCRAGGGRCCAC  (6) 
TTRCTACTACTACTACGGTATGGRCGTCTGGGGCCRAGGGRCCRC  (6) 
TRCTACTRCTACTACGGTATGGACGTCTGGGOCCARGGGRCCAC  (6) 
C111-103  (2119)  RGTRR6T66T  C 
CI11-106  (8P4)  66TTTTTGGRGTGGTTATTRC6  G6 
CIII-I060  (XP'I)  TTRCTRTGGTTCGGGGRG  CCGTGCGTCA 
CIII-I12  (K4)  6TGGRTRCRGCTATGG 
CII1-124  (21/IO)  TTRTGRTTACGTTTGGGGGRGTRTCGTTR  C(T) 
C|1|-139  (21/10)  TGGGGGRGAGA  RCCTTTGCRRRRGRTTR  (DIR2)  TCGGGRTTGGGCTT R  (HI)  ATRGCAGCflGCTGG 
CIII-145  (LR2)  GGACRTTGTRGTGGTGGTRGCTGCTRC  AAGflTRGGGTT 
CTRCTTCGGTATGGRCGTCTGGGGCCARGGGACCAC  (6) 
GRCTRCTGGGGCCRGGGACCGT (4) 
TTTGACTACTGGGGCCAGGGRCGCT  (4) 
AflTRCTRCTRCGGTRTGGACGTCTGGGGCCRRGGGACCflC  (6) 
flCARCTGGTTCGflCCCCTGGGGCCflGGGARCCCT  {S) 
tTGACTACTGGGGCCRGGGAACCCT  (4) 
TTTCTACTRCTRCTACGGTflTGGACGTCTGGGGCCARGGGflCCAC  (6) 
Figure 2.  DNA sequences of the DJ. regions derived from normal B cells obtained from the end of therapy remission marrow of three patients 
with B lineage lymphoblastic  leukemia  exhibiting fetal type DJ. joinings. See Fig. 1 for further explanation. 
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TdT activity. An alternative explanation for the lack of N 
regions is that bone marrow B cells (which give rise to ALL) 
might normally have a higher frequency of DJ. junctions 
that lack N  regions as compared with the other lymphoid 
tissues.  N region frequency was calculated from the joining 
sequences obtained from normal bone marrow of three young 
children (21-26 mo old). N  regions were present in 50/53 
(94.3%) DJ.junctions (data not shown), a frequency com- 
parable with the 86% and 90-100% reported for newborns 
and adults, respectively (13,  14). A high frequency of mul- 
tiple D  regions was  noted in  the DJ. junctions  obtained 
from the normal B cells of the young leukemic patients, sug- 
gesting the possibility that abnormalities in the VDJ recom- 
bination process are present in these children. 
To  determine  whether  the  DJ.  junctions  without  N 
regions in the 14 leukemias in children g3 yr old utilized 
specific D  or J, segments, we examined the frequency dis- 
tribution of such segments. The D gene family is composed 
of "~30 segments including multiple and duplicated loci, and 
thus patterns of utilization are difficult to analyze (1). XP 
was found to be the most commonly used D  family in the 
leukemias, consistent with the report by Sanz (13) for fetal 
tissue.  However, the leukemias showed a lower frequency of 
HQ52  utilization  (9.1%)  than that reported by Sanz (13) 
(14%) and Schroeder and Wang (29) (50%) for fetal tissue. 
J.4 and J.6 were the two predominant gene segments used 
in the leukemias comprising 80% of the sequences, whereas 
J.1 and J.2 usage was absent. In fetal tissue, Sanz (13) found 
J.4 usage to be the most common followed by J.3 and J.6, 
whereas Schroeder and Wang (29) found J.3 usage to be the 
most common followed by J.4 and J.5. These differences in 
J, and HQ52 usage found in fetal liver tissue may reflect in- 
dividual variation as samples were obtained from only one 
or two fetuses in each study (13, 29). 
Consequently, developmental stage-specific trends in the 
usage of D  and J. gene segments in fetal B cells have been 
consistently demonstrated only for the D  segment HQ52, 
and this usage varies widely (13,  29).  While HQ52 usage 
appears  to be a marker of fetal-derived B cells,  its absence 
does not imply a more developmentally mature stage. Thus, 
the absence of N  regions in the CDR 3 sequences appears 
to be a more useful marker of fetal origin. The vast majority 
(87.5%) of leukemias occurring in children g3 yr old lacked 
N  regions at the DJ. junction,  suggesting that they arose 
from a transformation event in utero when the pool of fetal 
lymphoid cells is largest. Furthermore, the sharp decrease in 
the frequency of DJ. junctions lacking N regions after 3 yr 
of age suggests that some leukemias initiated during fetal life 
require a maximum of 3 yr to become clinically evident. The 
absence of N regions observed in a small fraction of leukemic 
and normal B lymphocytes present later in life may represent 
a DJ. joining event that occurred during fetal development 
in a long-lived B cell or may simply indicate that Tdt was 
inactive at the time of DJ, joining in a developmentally ma- 
ture lymphoid ,cell. 
Greaves (30) has proposed a two-step mutation model in 
B lineage ALL in which the first event occurs in utero in 
association with an ontogenic drive to expand B cell precursors 
in liver and marrow. The second event produces clinically 
overt leukemia and is associated with the proliferative stress 
elicited in infants by the rapid onset of immune responses 
to exogenous antigens. Support for this latter event stems 
from the observation that the steep rise in the incidence rate 
of B precursor ALL follows shortly after serum antibody levels 
sharply rise toward adult levels during the first 2 yr of life 
(31).  Our observation would be compatible with Greave's 
hypothesis but would limit the in utero transforming event 
to primarily those leukemias that occur during the first  3 
yr of age. 
This work was supported by grants CA-10815 and CA-47983 from the National Cancer Institute,  and 
CH515 from the American Cancer Society. 
Address correspondence  to Giovanni Rovera, The Wistar Institute, 36th & Spruce Streets, Suite 374, Philadel- 
phia, PA 19104. 
Received for publication  18 June 1992 and in revised form  4 August  1992. 
References 
1.  Pascual, V., and J.D. Capra. 1991. Human immunoglobulin 
heavy-chain  variable  region genes: organization, polymorphism, 
and expression. Adv. Immunol. 49:1. 
2.  Blackwell, T.K., and F.W. Alt. 1989. Molecular characteriza- 
tion of the lymphoid V(D)J recombination activity. J. Biol. 
Chem. 264:10327. 
3.  Lewis, S., and M. Gellert. 1989. The mechanism of antigen 
receptor gene assembly. Cell. 59:585. 
4.  Kallenbach, S., N. Doyen, M.F. D'Andon,  and F. Rougeon. 
1992. Three lymphoid-specific  factors account for all junctional 
diversity characteristic of somatic assembly of T-cell receptor 
and immunoglobulin genes.  Proa Natl. Acad. Sci. USA. 89:2799. 
5.  Shatz, D.G., M.A.  Oettinger,  and D. Baltimore. 1989. The 
V(D)J recombination activating gene, RAG-1. Cell. 59:1035. 
6.  Oettinger,  M.A., D.G. Schatz, C. Gorka, and D. Baltimore. 
1990. RAG-1 and RAG-2, adjacent genes that synergistically 
activate V(D)J recombination. Science (Wash. DC). 248:1517. 
7.  Shinkai, Y., G. Rathbun,  K.-P. Lam, E.M. Ohz, V. Stewart, 
1580  Fetal Type DJH Joining in Young Children with B Precursor Leukemia M. Mendelsohn, J. Charron, M. Datta, F. Young, A.M. Stall, 
and F.W. Alt. 1992. RAG-2-deficient mice lack mature lym- 
phocytes owing to inability to initiate V(D)J rearrangement. 
Cell.  68:855. 
8.  Mombaerts, P., J.  Iacomini, R.S. Johnson,  K, Herrup,  S. 
Tonegawa, and V.E. Papaioannou.  1992. RAG-I-Deficient  mice 
have no mature B and T lymphocytes. Cell. 68:869. 
9.  LafaiUe,  J.J.,  A. DeCloux,  M. Bonneville, Y. Takagaki, and 
S. Tonegawa. 1989. Junctional sequences of T cell receptors 
3'~ genes: implications for 3'~ T cell lineages and for a novel 
intermediate of V-(D)-J joining.  Cell. 59:859. 
10.  Feeney,  A.J. 1990. Lack  of N regions  in fetal  and neonatal  mouse 
immunoglobulin  V-D-J junctional  sequences. J.  Exp.  Med. 
172:1377. 
11.  Bangs, L.A., I.E. Sanz, andJ.M. Teale. 1991. Comparison of 
D, J. and junctional diversity in the fetal, adult, and aged B 
cell repertoires. J. Immunol.  146:1996. 
12.  Gu, H., I. F6rster, and K. Rajewsky. 1990. Sequence  homolo- 
gies, N sequence insertion and J, gene utilization in V.DJ, 
joining: Implications for the joining mechanism and the on- 
cogenic timing of Lyl B cell and B-CLL progenitor genera- 
tion. EMBO (Eur. Mol. Biol. Organ.) J.  9:2133. 
13.  Sanz, I. 1991. Multiple mechanisms participate in the genera- 
tion of  diversity  of human H chain CDR3 regions.J. Immunol. 
147:1720. 
14.  Yamada, M., R. Wasserman, B.A. Reichard, S. Shane, A.J. 
Caton, and G. Rovera. 1991. Preferential  utilization of specific 
immunoglobulin heavy  chain diversity and joining segments 
in adult human peripheral blood B lymphocytes.  J. Ex  F Med. 
173:395. 
15.  Ikothenberg, E., and D. Triglia. 1983. Clonal proliferation un- 
linked to terminal deoxynucleotidyl transferase synthesis in 
thymocytes of young mice..J. Immunol.  130:1627. 
16.  Gregoire, K.E.,  I.  Goldschneider, R.W.  Barton,  and  F.J. 
Bollum. 1979. Ontogeny of terminal deoxynucleotidyl trans- 
ferase-positive cells in lymphohemopoietic tissues of rat and 
mouse. J. Immunol.  123:1347. 
17.  Korsmeyer,  S.J., A. Arnold, A. Bakhshi, J.V. Ravetch, U. Sie- 
benlist, P.A. Hieter, S.O. Sharrow, T.W. LeBien,  J.H. Kersey, 
D.G. Poplack, P. Leder, and T.A. Waldmann. 1983. Immuno- 
globulin gene rearrangement and cell surface antigen expres- 
sion in  acute lymphocytic leukemias of T-cell and  B-cell 
precursor origins. J.  Clin.  Invest. 71:301. 
18.  Nadler, L.M., S.J. Korsmeyer, K.C. Anderson, A.W. Boyd, 
B. Slaughenhoupt, E. Park, J. Jensen, F. Coral, R.J. Mayer, 
S.E. Sallan,  J. Ritz, and S.F. Schlossmann. 1984. B cell origin 
of non T-ceU acute lymphoblastic leukemia. A model for dis- 
crete stages of  neoplastic and normal pre-B cell differentiation. 
J.  Clin.  Invest. 74:332. 
19.  Greaves,  M.E 1986. Differentiation-linked  leukaemogenesis  in 
lymphocytes. Science (Wash. DC).  234:697. 
20.  Foon, K.A., and R.E Todd III. 1986. Immunologic classifi- 
cation of leukemia and lymphoma. Blood. 68:1. 
21.  Sambrook, J., E.E Fritsch, and T. Maniatis. 1989. Molecular 
Cloning: A Laboratory Manual. 2nd Ed. Cold Spring Harbor 
Laboratory, Cold Spring Harbor, NY. 
22.  Higuchi, R. 1989. Simple and rapid preparation of samples 
for PCR. In PCR Technology:  Principles and Applications  for 
DNA Amplification.  H.A. Erlich, editor. Stockton Press, New 
York. 31-38. 
23.  Saiki, R.K., D.H. Gelfand, S. Stoffel, S.J. Scharf, K. Higuchi, 
G.T. Horn, K.T. Mullis, and H.A. Ehrlich.  1988. Primer- 
directed enzymatic amplification  of  DNA with a thermostable 
DNA polymerase. Science (Wash. DC).  239:487. 
24.  Yamada,  M., S. Hudson, O. Toumay,  S. Bittenbender,  S. Shane, 
B. Lange, Y. Tsujimoto, A.J. Caton, and G. Rovera. 1989. De- 
tection of minimal disease in hematopoietic malignancies of 
the B-cell lineage  by using third-complementarity-determining 
region (CDR-III)-specific probes. Proa Natl. Acad. Sci. USA. 
86:5123. 
25.  Sanger, F., S. Nicklen, and A.R. Coulson.  1977. DNA se- 
quencing with chain-terminating inhibitors. Pro~ Natl. Acad. 
Sci.  USA.  74:5463. 
26.  Wasserman, R., Y. Ito, N. Galili, M. Yamada, B.A. Reichard, 
S. Shane, B. Lange,  and G. Rovera. 1992. The pattern of  joining 
(J.) gene usage in the human immunoglobulin heavy chain 
is established predominantly at the B precursor cell stage.  J. 
Immunol.  149:511. 
27.  Wasserman, R.,  M.  Yamada, Y.  Ito,  L.R.  Finger, B.A. 
Reichard, S. Shane, B. Lange, and G. Rovera. 1992. V. gene 
rearrangement events can modify the immunoglobulin heavy 
chain during  progression of B-lineage acute lymphoblastic 
leukemia. Blood. 79:223. 
28.  Yamada, M., R. Wasserman, B. Lange, B.A. Reichard, R.B. 
Womer, and G. Rovera. 1990. Minimal  residual  disease  in child- 
hood B-lineage  lymphoblastic  leukemia: persistence  of  leukemic 
cells during the first 18 months of treatment. N. Engl.J. Med. 
323:448. 
29.  Schroeder, H.W., Jr., and J.Y. Wang. 1990. Preferential utili- 
zation of  conserved immunoglobulin heavy  chain variable gene 
segments during human fetal life. Proa Natl. Acad. Sci. USA. 
87:6146. 
30.  Greaves, M.F. 1988. Speculations on the cause of childhood 
acute lymphoblastic leukemia. Leukemia  (Baltimore). 2:120. 
31.  AUansmith, M., B.H. McClellan, M. Butterworth,  and J.R. 
Maloney. 1968. The development of immunoglobulin levels 
in man. J. Pediatr. 72:276. 
1581  Wasserman  et al. 